| Toyama Chemical Co., Ltd. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120046326 | DRUG CONTAINING BENZOPHENONE DERIVATIVE OR ITS SALT - Pharmaceutical agents characterized by containing benzophenone derivatives represented by the general formula: | 02-23-2012 |
| 20110275797 | N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF - An N-acyl anthranilic acid derivative represented by general formula (1) or a salt thereof is useful for prevention or treatment of diseases associated with excessive production of collagen. (In the formula, R | 11-10-2011 |
| 20110263866 | PROCESS FOR PRODUCTION OF 3-[5-[4-(CYCLOPENTYLOXY)-2-HYDROXYBENZOYL]-2-[(3-OXO-2-SUBSTITUTED-2,3-DI- HYDRO-1,2-BENZISOXAZOL-6-YL)METHOXY]PHENYL]PROPIONATE ESTER AND INTERMEDIATE FOR THE PROCESS - A 6-(halomethyl)-1,2-benzisoxazol-3(2H)-one derivative represented by the formula: | 10-27-2011 |
| 20110245228 | PROTEIN KINASE C ACTIVITY ENHANCER CONTAINING ALKYL ETHER DERIVATIVE OR SALT THEREOF - Disclosed is a protein kinase C enhancer characterized by containing a benzothiophene alkyl ether derivative represented by the general formula below or a salt thereof. | 10-06-2011 |
| 20110112066 | PREVENTIVE/REMEDY FOR RETINAL NERVE DISEASES CONTAINING ALKYL ETHER DERIVATIVES OR SALTS THEREOF - An alkyl ether derivative represented by the following general formula [1] | 05-12-2011 |
| 20110098484 | PROCESS FOR PRODUCTION OF 1-(3-(2-(1-BENZOTHIOPHEN-5-YL)- ETHOXY)PROPYL)AZETIDIN-3-OL OR SALTS THEREOF - A Process for production of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salts thereof which comprises using as a starting compound as a (phenylthio)acetic acid derivative or salts thereof represented by the general formula: | 04-28-2011 |
| 20110077413 | NOVEL BENZOTHIOPHENE OXIDE DERIVATIVE AND SALT THEREOF - Disclosed is a benzothiophene oxide derivative represented by the general formula (wherein R | 03-31-2011 |
| 20110046381 | NOVEL 4-{3-[4-(3-{4-[AMINO (BUTOXYCARBONYLIMINO) METHYL] PHENOXY} PROPYL)-1-PIPERIDINYL] PROPOXY]-N'-(BUTOXYCARBONYL) BENZAMIDINE CRYSTALS - Problems To provide novel crystals of 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy}-N′-(butoxycarbonyl)benzamidine. | 02-24-2011 |
| 20110039813 | METHOD OF UTILIZATION OF COMBINATION OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND IMMUNOSUPPRESSING AGENT, AND PHARMACEUTICAL COMPOSITION COMPRISING THESE COMPONENTS - Disclosed are use of a benzophenone derivative represented by general formula (I) or a salt thereof and one or more immunosuppressing agents in combination, and a pharmaceutical composition containing the benzophenone derivative or a salt thereof and one or more immunosuppressing agents. The use and the composition are useful for treatment or prevention of autoimmune diseases and the like. (In the formula, R | 02-17-2011 |
| 20110020366 | USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF ALPHA INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR - Disclosed are a use of a benzophenone derivative or a salt thereof and one or more TNFα inhibitors in combination, and a pharmaceutical composition containing the benzophenone derivative or a salt thereof and one or more TNFα inhibitors. The use and the composition are useful for treatment or prevention of autoimmune diseases and the like. | 01-27-2011 |
| 20100286394 | ORGANIC AMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINECARBONITRILE AND METHOD FOR PRODUCING THE SAME - Disclosed is an organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile, which is excellent in crystallinity and useful as a production intermediate for 6-fluoro-3-hydroxy-2-pyrazinecarboxamide. | 11-11-2010 |
| 20100249417 | NOVEL NAPHTHYRIDINE DERIVATIVE MONOHYDRATE AND METHOD FOR PRODUCING THE SAME - Disclosed is 1-(2-(4-((2,3-dihydro(1,4)dioxino(2,3-c)pyridin-7-ylmethyl)amino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one monohydrate, which has strong antibacterial activity. The compound is highly safe and useful as an original drug for pharmaceutical preparations. Also disclosed is a method which is useful for producing 1-(2-(4-((2,3-dihydro(1,4)dioxino(2,3-c)pyridin-7-ylmethyl)amino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one monohydrate. | 09-30-2010 |
| 20100240891 | DRUG CONTAINING BENZOPHENONE DERIVATIVE OR ITS SALT - Pharmaceutical agents characterized by containing benzophenone derivatives represented by the general formula: | 09-23-2010 |
| 20100184997 | PROTEIN KINASE C ACTIVITY ENHANCER CONTAINING ALKYL ETHER DERIVATIVE OR SALT THEREOF - Disclosed is a protein kinase C enhancer characterized by containing a benzothiophene alkyl ether derivative represented by the general formula below or a salt thereof. | 07-22-2010 |
| 20100168418 | NOVEL NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF - A nitrogen-containing heterocyclic compound represented by the general formula: wherein the dashed line represents a single bond or a double bond; R | 07-01-2010 |
| 20100098750 | PHARMACEUTICAL COMPOSITION COMPRISING PHENYLAMIDINE DERIVATIVE AND METHOD OF USING THE PHARMACEUTICAL COMPOSITION IN COMBINATION WITH ANTIFUNGAL AGENT - A pharmaceutical composition comprising a phenylamidine derivative or a salt thereof, represented by a general formula, | 04-22-2010 |
| 20100087447 | PHARMACEUTICAL COMPOSITION COMPRISING PYRAZINE DERIVATIVE, AND METHOD OF USING PYRAZINE DERIVATIVE IN COMBINATION - Disclosed is a pharmaceutical composition comprising a pyrazine derivative represented by the general formula: | 04-08-2010 |
| 20100075941 | PREVENTIVE/REMEDY FOR RETINAL NERVE DISEASES CONTAINING ALKYL ETHER DERIVATIVES OR SALTS THEREOF - An alkyl ether derivative represented by the following general formula [1] | 03-25-2010 |
| 20100063273 | NOVEL CRYSTAL OF PIPERACILLIN SODIUM - Disclosed are a novel crystal of piperacillin sodium which has diffraction angles of 3.7°, 5.5°, 7.3°, 11.6°, 14.5° and 18.0° and a novel crystal of piperacillin sodium which has diffraction angles of 5.6°, 7.8°, 12.3°, 15.5°, 17.5°, 23.3°, 24.8° and 28.5° expressed by 2θ in the powder X-ray diffraction analysis. The crystals have excellent stability and solubility and a low water-absorbing property, is extremely easy to be handled in the manufacturing process for a medicinal substance and in the packing during the preparation process for a pharmaceutical product. A pharmaceutical preparation for injection comprising any one of the crystals is useful. | 03-11-2010 |
| 20100016602 | NOVEL ARYLAMIDINE DERIVATIVE, SALT THEREOF AND ANTIFUNGAL AGENT CONTAINING THOSE - Disclosed is an arylamidine derivative represented by the following general formula: | 01-21-2010 |
| 20090275757 | NOVEL CRYSTAL OF 3-[5-[4-(CYCLOPENTYLOXY)-2- HYDROXYBENZOYL]-2-[(3-HYDROXY-1,2-BENZISOXAZOL-6- YL)METHOXY]PHENYL]PROPIONIC ACID - The crystal of 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propionic acid having peaks at the position of 14.0, 16.0, 23.3, 23.7 and 26.3° and the crystal of 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propionic acid having peaks at the position of 14.6, 23.1, 24.7, 25.6 and 26.0° on 2θ of diffraction angle in a powder X-ray diffraction pattern have a small specific volume, are hard to be charged with electricity, are easily handled and are useful for an active pharmaceutical ingredient of excellent anti-rheumatic agents. | 11-05-2009 |
| 20090240052 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF - An anthranilic acid derivative represented by the general formula (X) [wherein R | 09-24-2009 |
| 20090209512 | NEUROGENESIS INDUCER OR NEUROPATHY THERAPEUTIC AGENT COMPRISING ALKYL ETHER DERIVATIVE OR SALT THEREOF - Disclosed is an agent comprising a benzothiophene alkyl ether derivative represented by the general formula below or a salt thereof: | 08-20-2009 |
| 20090198063 | NOVEL HETEROCYCLIC COMPOUND OR SALT THEREOF AND INTERMEDIATE THEREOF - Disclosed is a compound represented by the general formula: [wherein R | 08-06-2009 |
| 20090163562 | ORAL COMPOSITION COMPRISING 3-[5-[4-(CYCLOPENTYLOXY) -2-HYDROXYBENZOYL]-2-[(3-HYDROXY-1,2-BENZISOXAZOL-6- YL)METHOXY]PHENYL]PROPIONIC ACID OR SALT THEREOF - An oral composition contains 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propionic acid or a salt thereof and polyvinylpyrrolidone is advantageous as an oral medication composition (1) which can be produced without requiring new manufacturing equipment; (2) which can be produced with simple steps; (3) which maintains stable solubility even with changes in the pH of the gastrointestinal tract and of which gastrointestinal tract absorption is improved. | 06-25-2009 |
| 20090118169 | NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF - A compound comprising the atom corresponding to N | 05-07-2009 |
| 20090111992 | ALKYL ETHER DERIVATIVES OR SALTS THEREOF - An alkyl ether derivative represented by the general formula: | 04-30-2009 |
| 20090105474 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF - The anthranilic acid derivative or the salt thereof represented by the general formula | 04-23-2009 |
| 20090099369 | PROCESS FOR PRODUCTION OF 3-[5-[4-(CYCLOPENTYLOXY)-2-HYDROXYBENZOYL]-2-[(3-OXO-2-SUBSTITUTED-2,3-DI- HYDRO-1,2-BENZISOXAZOL-6-YL)METHOXY]PHENYL]PROPIONATE ESTER AND INTERMEDIATE FOR THE PROCESS - A preparation method using as an intermediate 6-(halomethyl)-1,2-benzisoxazol-3(2H)-one derivative represented by general formula | 04-16-2009 |
| 20090093453 | NEUROGENESIS INDUCER OR NEUROPATHY THERAPEUTIC AGENT COMPRISING ALKYL ETHER DERIVATIVE OR SALT THEREOF - Disclosed is an agent comprising a benzothiophene alkyl ether derivative represented by the general formula below or a salt thereof: | 04-09-2009 |
| 20090087480 | PHARMACEUTICAL COMPOSITION AND METHOD USING ANTIFUNGAL AGENT IN COMBINATION - A pharmaceutical composition containing one or more antifungal agents selected from an arylamidine derivative represented by the general formula: | 04-02-2009 |
| 20090069576 | PROCESS FOR PRODUCTION OF 1-(3-(2-(1-BENZOTHIOPHEN-5-YL)-ETHOXY)PROPYL)AZETIDIN-3-OL OR SALTS THEREOF - A Process for production of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salts thereof which comprises using as a starting compound as a (phenylthio)acetic acid derivative or salts thereof represented by the general formula: | 03-12-2009 |
| 20080319016 | Novel Arylamidine Derivative, Salt Thereof, and Antifungal Containing These - An arylamidine derivative represented by the general formula (wherein R | 12-25-2008 |
